Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy

被引:254
|
作者
Anolik, Jennifer H. [1 ]
Barnard, Jennifer [1 ]
Owen, Teresa [1 ]
Zheng, Bo [1 ]
Kemshetti, Sunil [1 ]
Looney, R. John [1 ]
Sanz, Inaki [1 ]
机构
[1] Univ Rochester, Sch Med, Rochester, NY 14642 USA
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 09期
关键词
T-CELLS; IN-VIVO; RHEUMATOID-ARTHRITIS; CYTOKINE SECRETION; SOMATIC MUTATION; DISEASE-ACTIVITY; RITUXIMAB; RECONSTITUTION; POPULATION; TRIAL;
D O I
10.1002/art.22810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Recent data suggest that the reconsti- tuting peripheral B cell compartment after B cell depletion therapy may be functionally immature, with a preponderance of transitional B cells and a paucity of memory B cells. This study was undertaken to determine the magnitude, duration, and cause of these defects in rituximab-treated systemic lupus erythematosus (SLE) patients. Methods. Fifteen patients with SLE previously treated with rituximab as part of a phase I/II dose-escalation study were evaluated during a long-term followup (mean followup period 41 months). B cells from peripheral blood and tonsils were assessed using multicolor flow cytometry, and their developmental pathway was classified based on the expression of defined surface markers. Results. Reconstitution of peripheral blood CD27+ memory B cells was delayed for several years after B cell depletion therapy in a subset of patients with prolonged clinical responses and autoantibody normalization. This delay correlated with the degree of expansion of B cells of a transitional phenotype during the B cell reconstitution phase (P = 0.005) and the absence of baseline autoantibodies directed against extractable nuclear antigens (RNP, Sm, Ro antigen, La antigen). Despite the paucity of peripheral blood memory cells and the prolonged expansion of functionally immature transitional B cells, tonsil biopsy tissues revealed active germinal center (GC) reactions, but with decreased Fc receptor homolog 4-positive memory B cells. Conclusion. These results suggest heterogeneity in the B cell depletion and reconstitution process that impacts clinical and immunologic outcomes in SLE. The presence of GC reactions, but with altered memory B cell subpopulations in tonsils, suggests that peripheral blood memory cell reconstitution lags behind a slow secondary lymphoid tissue recovery, with important implications for immunologic competence and tolerance.
引用
收藏
页码:3044 / 3056
页数:13
相关论文
共 50 条
  • [31] CHARACTERIZATION OF PERIPHERAL BLOOD B-CELL SUBSET IN UNTREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS
    Gerasimova, E.
    Tabakov, D.
    Aleksankin, A.
    Shayakhmetova, R.
    Popkova, T.
    Avdeeva, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1150 - 1151
  • [32] Treatment of Refractory Systemic Lupus Erythematosus Autoimmune Hemolytic Anemia with B cell Depletion Therapy: B cell subsets as a Potential Predictor of Response
    Hulinska, Hana
    Anolik, Jennifer
    Furie, Richard
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4026 - 4026
  • [33] Auto-reactive B cells in systemic lupus erythematosus patients impair iNKT cell frequency and function, which is restored after B cell depletion therapy
    Bosma, A.
    Abdel-Gadir, A.
    Isenberg, D. A.
    Jury, E. C.
    Mauri, C.
    IMMUNOLOGY, 2010, 131 : 39 - 39
  • [34] Auto-reactive B cells in systemic lupus erythematosus patients impair iNKT cell frequency and function, which is restored after B cell depletion therapy
    Bosma, A.
    Abdel-Gadir, A.
    Isenberg, D. A.
    Jury, E. C.
    Mauri, C.
    IMMUNOLOGY, 2010, 131 : 29 - 29
  • [35] B-cell-targeted therapy for systemic lupus erythematosus - An update
    Ding, Changhai
    Foote, Simon
    Jones, Graeme
    BIODRUGS, 2008, 22 (04) : 239 - 249
  • [36] Is B Cell-Targeted Therapy Effective in Systemic Lupus Erythematosus?
    Paran, Daphna
    Naparstek, Yaakov
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (02): : 98 - 103
  • [37] The immunological basis of B-cell therapy in systemic lupus erythematosus
    Mok, Mo Yin
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2010, 13 (01) : 3 - 11
  • [38] Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
    Iwata, Shigeru
    Saito, Kazuyoshi
    Tokunaga, Mikiko
    Yamaoka, Kunihiro
    Nawata, Masao
    Yukawa, Sonosuke
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyagawa, Ippei
    Kubo, Satoshi
    Tanaka, Yoshiya
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 633 - 641
  • [39] Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
    Patrick Muller
    Kashfia Chowdhury
    Caroline Gordon
    Michael R. Ehrenstein
    Caroline J. Doré
    Trials, 21
  • [40] Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
    Muller, Patrick
    Chowdhury, Kashfia
    Gordon, Caroline
    Ehrenstein, Michael R.
    Dore, Caroline J.
    TRIALS, 2020, 21 (01)